相关实验视频
Updated: Jul 18, 2026

10:53
Ultrasonic Assessment of Myocardial Microstructure
Published on: January 14, 2014
概括
在急性心肌梗塞后的前20小时内,心室失常 (PVC) 的严重程度与心脏病发作的大小相关. 这种关系在没有先前心脏病发作的患者中更为强烈,表明PVC是心肌损伤的潜在指标.
科学领域:
- 心脏病学 心脏病学
- 临床电生理学 临床电生理学
- 生物医学工程 生物医学工程
背景情况:
- 急性心肌梗塞 (AMI) 可以导致严重的并发症,包括心室失律症.
- 腹腔失律症的严重程度与心肌损伤的程度之间的关系尚未完全理解.
- 预测心律失常严重程度的因素的早期识别对于AMI后的患者管理至关重要.
研究的目的:
- 为了前性地研究心室节律失常症与因肌性心脏病入院患者的酶估计的心脏病大小之间的相关性.
- 评估先前心肌梗塞对这种关系的影响.
- 为了探索心律失常,心率和利多卡因管理之间的关联.
主要方法:
- 对因AMI住院的患者进行前性研究.
- 腹腔失常的测量是用过早腹腔脱极化 (PVC) 率超过25个PVC/小时的总时间来测量腹腔失常.
- 对心脏病发作大小指数 (ISI) 的酶估计.
- 对心律失常和利多卡因剂量的回顾性计算机分析.
主要成果:
- 在心室节律失常的持续时间和心脏病发作大小指数 (ISI) 之间发现了显著的正相关性.
- 当以前心肌梗塞的患者被排除在外时,这种相关性更强.
- 在PVC频率和平均心率之间没有明显的相关性,也没有在PVC合间隔和ISI或心率之间.
- 在总的利多卡因和心律失常的严重程度之间发现了中等,显著的相关性.
结论:
- 在AMI住院的最初20小时内,心室节律失常的持续性和严重性与酶估计的心脏病发作大小显著相关.
- 心室节律失常可能作为心脏病发作大小的临床指标,特别是在没有心肌梗塞病史的患者中.
- 利多卡因的使用与心律失常的严重程度相关,这表明它可以用于管理这些事件.
相关概念视频
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...

